{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:52:53Z","timestamp":1790553173367,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/iop.0b013e318293764c","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T13:45:06Z","timestamp":1373377506000},"page":"290-293","source":"Crossref","is-referenced-by-count":24,"title":["Toll-Like Receptors and Vascular Markers in Ocular Rosacea"],"prefix":"10.1097","volume":"29","author":[{"given":"Edward J.","family":"Wladis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devang P.","family":"Bhoiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro P.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea.","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"R2-10-20210129","first-page":"16","article-title":"Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses.","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity.","volume":"15","author":"Yamasaki","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/IOP.0b013e31824dd9d4","article-title":"Molecular biologic assessment of cutaneous biopsies of ocular rosacea.","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R5-10-20210129","first-page":"541","article-title":"Increased MAPK and NF-B expression of Langerhans cells is dependent on TLR2 and TLR4, and increased IRF-3 expression is partially dependent on TLR4 following UV exposure.","volume":"4","author":"Wang","year":"2011","journal-title":"Mol Med Rep"},{"key":"R6-10-20210129","first-page":"614","article-title":"Inflammation in rosacea and acne: Implications for patient care.","volume":"10","author":"Fleischer","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37hCAP-18.","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1600-0560.2006.00695.x","article-title":"Lymphangiogenesis and angiogenesis in non-phymatous rosacea.","volume":"34","author":"Gomaa","year":"2007","journal-title":"J Cutan Pathol"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.","volume":"15","author":"Schwab","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1100\/tsw.2010.230","article-title":"The role of the TGF- coreceptor endoglin in cancer.","volume":"10","author":"Perez-Gomez","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0005-2760(94)00059-X","article-title":"Differences in the metabolism of eicosatetraenoic (20:4(n-6)), tetracosatetraenoic (24:4(n-6)) and triacontatetraenoic (30:4(n-6)) acids in human neutrophils.","volume":"1213","author":"Robinson","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbadis.2009.07.003","article-title":"The emerging role of TGF-beta superfamily coreceptors in cancer.","volume":"1792","author":"Bernabeu","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cardiores.2005.11.020","article-title":"Reduced angiogenic responses in adult Endoglin heterozygous mice.","volume":"69","author":"Jerkic","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R15-10-20210129","first-page":"809","article-title":"Modulation of TNF-alpha-induced endothelial cell activation by glucosamine, a naturally occurring amino monosaccharide.","volume":"22","author":"Ju","year":"2008","journal-title":"Int J Mol Med"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"H969","DOI":"10.1152\/ajpheart.00400.2008","article-title":"Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling.","volume":"295","author":"Sumagin","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvp332","article-title":"Targeting cancer vasculature via endoglinCD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.","volume":"86","author":"Fonsatti","year":"2010","journal-title":"Cardiovasc Res"},{"key":"R18-10-20210129","first-page":"7846","article-title":"Antiangiogenic therapy of established tumors in human skinsevere combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.","volume":"61","author":"Takahashi","year":"2001","journal-title":"Cancer Res"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00007890-199903150-00015","article-title":"A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group.","volume":"67","author":"Salmela","year":"1999","journal-title":"Transplantation"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e318293764c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:54:05Z","timestamp":1620957245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201307000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e318293764c","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}